Clinical Trials and Research


Ramsay is proud to play a leading role in Australia’s health and medical research sector by driving research through the
Ramsay Research & Development Network, the
Ramsay Hospital Research Foundation, and our
Research Ethics, and
Governance Unit.
The Clinical Trials and Research Unit at Sunshine Coast Private Hospital is part of the Ramsay Research & Development Network that operates across 20+ Ramsay Health Care facilities throughout Australia. Our hospital actively encourages and supports clinical research as a key contributor to improved patient outcomes. We believe that providing early access to promising clinical trials is essential to delivering high-quality, leading-edge care; consistent with the standard of care at our hospital.
Participating in Research
If you’re interested in participating in a clinical trial, you may be eligible for one currently being conducted at Sunshine Coast University Private Hospital, as listed below. Please speak with your doctor to explore your options. If you’re interested in participating in a clinical trial, which is not offered at Sunshine Coast University Private Hospital your doctor may be able to help you find another trial that is suitable for you. Alternatively, you can search for suitable clinical trials through the Australian Clinical Trials website or ClinTrial Refer.
Conducting Research
Our hospital has a dedicated clinical trials & research unit that supports the conduct of research across all aspects of the hospital. Our site manager and the broader research team can provide advice on how to get involved.
For any inquiries, please contact Renae Jackson, Clinical Trials and Research Manager via email at
JacksonRenae@ramsayhealth.com.au
Current Trials
| Study Name |
Therapeutic Area |
Recruitment Status |
Lead Investigator |
| ABL103 |
Advanced metastatic solid tumours |
Currently recruiting |
Dr Michelle Morris |
| ADCX-020 |
Advanced metastatic solid tumours |
Currently Recruiting |
Dr Michelle Morris |
| ALK201-01 |
Advanced solid tumours |
Currently recruiting |
Dr Michelle Morris |
| AP402-101 |
Advanced solid tumours |
Currently recruiting |
Dr Michelle Morris |
| ARC101 |
Advanced solid tumours |
Currently recruiting |
Dr Michelle Morris |
| AT-0174 |
Advanced solid tumors |
Currently recruiting |
Dr Jeremy Long |
| BBI-4182-101 |
Advanced gastric and gastroesophageal cancer |
Currently recruiting |
Dr Michelle Morris |
| BG-C477-101 |
Advanced solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| BGB-21447 |
Metastatic breast cancer |
Currently recruiting |
Dr Michelle Morris |
| BL0020-101 |
Advanced solid tumours |
Currently recruiting |
Dr Michelle Morris |
| CA224-127 (RELATIVITY) |
Untreated metastatic or unresectable melanoma |
Closed to recruitment |
Dr Jeremy Long |
| CAMBRIA |
Early breast cancer |
Closed to recruitment |
Dr Michelle Morris |
| Capitello-281 |
Metastatic hormone-sensitive prostate cancer and PTEN deficiency |
Closed to recruitment |
Dr Michelle Morris |
| CIBI343A101 |
Locally advanced unresectable or metastatic solid tumours |
Closed to recruitment |
Dr Michelle Morris |
| D740AC00001 |
Rheumatoid Arthritis or Systemic Lupus Erythematosus |
Currently recruiting |
Dr Sue Thackwray |
| DB-1311-01 |
Advanced metastatic solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| DB1311-201 |
Advanced metastatic solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| Evoke-2 GS-US-576-6220 |
Advanced metastatic non-small-cell lung cancer |
Closed to recruitment |
Dr Jeremy Long |
| GS-US-576-7321 |
Advanced triple-negative breast cancer |
Currently recruiting |
Dr Jeremy Long |
| Jazz (HER2+) |
Metastatic HER2-positive breast cancer |
Currently recruiting |
Dr Michelle Morris |
| MK3457-587 |
Advanced solid tumours |
Closed to recruitment |
Dr Jeremy Long |
| SBO-154 |
Advanced solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| TAK-279-3002 |
Psoriatic arthritis |
Currently recruiting |
Dr Sue Thackwray |
| TAK-279-3003 |
Psoriatic arthritis |
In start-up |
Dr Sue Thackwray |
| Veritac-2 C4891001 (PFIZER) |
Advanced metastatic breast cancer |
Closed to recruitment |
Dr Michelle Morris |
| VIB305 |
Advanced solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| XL092-002 (Exelixis) |
Advanced solid tumours |
Currently recruiting |
Dr Andrew Schmidt |
| YN001-004 |
Coronary atherosclerosis |
Currently recruiting |
Dr Sue Thackwray |
Expression of interest
Fill in the form below to express your interest in participating in a clinical trial, and a member of our team will be in contact to assess your suitability for participation.